Effects of aminoguanidine on lipid and protein oxidation in diabetic rat kidneys

International Journal of Experimental Diabetes Research

Volumn 3, Issue 2, 2002, Pages 145-151

  Yavuz, Dilek Gogas ^a   Küçükkaya, Belgin ^a   Ersöz, H Önder ^a   Yalçin, A Süha ^a   Emerk, Kaya ^a   Akalin, Sema ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; ANTIOXIDANT; BICARBONATE; CARBONYL DERIVATIVE; DRINKING WATER; LIPID; NITRIC OXIDE; OXIDIZING AGENT; PROTEIN; TAP WATER; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; FEMALE; GLYCATION; KIDNEY HOMOGENATE; LIPID OXIDATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; RAT; REVIEW; STREPTOZOCIN DIABETES; STRESS;

ALBUMINURIA; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FEMALE; GUANIDINES; KIDNEY; KIDNEY CORTEX; LIPID METABOLISM; LIPID PEROXIDATION; NITRIC OXIDE; OXIDATION-REDUCTION; PROTEINS; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0036253802     PISSN: 15604284     EISSN: None     Source Type: Journal    
DOI: 10.1080/15604280214487     Document Type: Review

References (28)

1. Pathogenic role of advanced glycosylation end products in diabetic nephropathy
2. Roles of advanced glycation end-products in the progression of diabetic nephropathy
3. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes
4. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats
5. Cytotoxicity of advanced glycation end products is mediated by oxidative stress
6. Carbonyl stress in the pathogenesis of diabetic nephropathy
7. Lipoprotein oxidation and lipoprotein induced cell injury in diabetes
8. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm
9. Lipoprotein glycation and it's metabolic consequences
10. Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy
11. Effect of aminoguanidine on lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney
12. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine mediated renoprotection in diabetic rats
13. Role of nitric oxide in insulin dependent diabetes mellitus- related vascular complications
14. Levels of carbonyl groups in plasma proteins of type 2 diabetes mellitus subjects
15. Human studies related to protein oxidation: Protein carbonyl content as a marker of damage
16. Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy
17. Advanced glycation end products: A nephrologist's perspective
18. Retardation by Aminoguanidine of development of albuminuria, mesengial expansion and tissue fluorescence in streptozotocin-induced diabetic rat
19. Real time measurement of nitric oxide produced ex vivo by luminol-H2O2 chemiluminescence method
20. Chemiluminesence measurements for the detection of free radical species
21. Determination of carbonyl content in oxidatively modified proteins
22. Lipid peroxidation and activity of antioxidant enzymes in diabetic rats
23. Glutathion status, lipid peroxidation and kidney function in streptozotocin diabetic rats
24. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions
25. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking
26. Glomerular actions of nitric oxide
27. Renal nitric oxide production during early phase of experimental diabetes mellitus
28. Impaired nitric oxide release by glomeruli from diabetic rats